title: [Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
authors: Service des maladies infectieuses et tropicales, Clinique Ibrahima Diop Mar, CHU de Fann, avenue Cheikh Anta Diop, Dakar, Sénégal. nmmanga@hotmail.com
authors: N M
authors: NM
authors: Manga
authors: A
authors: A
authors: Poda
authors: N
authors: N
authors: Bazolo
authors: O
authors: O
authors: Sané
authors: G
authors: G
authors: Batista
authors: N F
authors: NF
authors: Guèye
authors: P S
authors: PS
authors: Sow
authors: C I
authors: CI
authors: Badiane
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D003951:Diagnostic Errors; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000209:etiology*; D019259:Lamivudine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015439:Leprosy, Borderline / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D015440:Leprosy, Lepromatous / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D009443:Neuritis / Q000209:etiology; D019829:Nevirapine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D012675:Senegal; D018119:Stavudine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014006:Tinea Capitis / Q000175:diagnosis
chemical_list: D000305:Adrenal Cortex Hormones; D019380:Anti-HIV Agents; D007917:Leprostatic Agents; D019259:Lamivudine; D003622:Dapsone; D019829:Nevirapine; D018119:Stavudine; D012293:Rifampin